Key benefits Why people compare it 1 Modulates 4,000+ genes (6% of human genome) toward healthier expression 2 70% improvement in skin laxity in double-blind clinical trials 3 35% increase in procollagen synthesis and dermal thickness 4 Suppresses 2,550 genes linked to inflammation, fibrosis, and metastasis 5 Promotes osteoblast differentiation and fracture healing 6 Neuroprotective activity in ischemia cell culture models 7 Reduces fibrinogen expression (cardiovascular risk marker) 8 Endogenous compound with established safety profile since 1973 discovery Deep research About GHK-Cu (Copper Peptide) GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex with a molecular weight of approximately 403.93 Da (including the copper ion)
(Peptide Sciences) Oncology & adjunctive therapy Interestingly, since senescent cells often accumulate in tissues post-chemotherapy and may contribute to relapse or fibrosis, FOXO4-DRI might serve as adjuncts in oncology (preclinical) by clearing therapy-induced senescent cells
Case reports and small open-label use in clinics pop up online, but without standardized outcome measures, no control groups, and no objective biomarkers
Studies evaluating the impact of GHK-Cu applied to the face have noted reduced fine lines and wrinkle depth
"Peptides and Ageing." Neuro Endocrinology Letters, 2002
